Finance Intern-T&E at Eli Lilly and Company

Shanghai, Shanghai, China

Eli Lilly and Company Logo
Not SpecifiedCompensation
InternshipExperience Level
InternshipJob Type
UnknownVisa
Healthcare, PharmaceuticalsIndustries

Requirements

  • 本科及以上学历在读学生,专业不限
  • 工作积极主动,具备良好的抗压能力和责任心
  • 每周可实习至少2天,实习期不少于3个月,优先考虑长期实习者
  • 寒暑假期间可每周实习5天,开学后每周可保证2-3天
  • 有相关财务实习经验者优先考虑

Responsibilities

  • 收集并装订员工纸质报销单据,核查是否附有发票原件
  • 根据公司报销政策,审核员工报销费用
  • 协助团队完成相关报告底稿,包括增值税(VAT)底稿的初步核查与校验
  • 支持财务部T&E小组的日常工作,如文件扫描、复印及发票整理
  • 解答员工关于纸质报销单据的咨询,协助查找相关账单
  • 协助制作财务部企业微信海报及财务部海报等内容
  • 参与录制及制作Concur报销系统操作指南
  • 学习并参与财务自动化相关项目,并进行经验分享

Skills

Finance
Expense Reimbursement
VAT
Document Scanning
Concur
Financial Reporting
Excel
Data Validation

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI